LEF1 Reduces Tumor Progression and Induces Myodifferentiation in a Subset of Rhabdomyosarcoma

Oncotarget - United States
doi 10.18632/oncotarget.13887
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Rhabdomyosarcoma Mimicking Wilms' Tumor

Sao Paulo Medical Journal
Medicine
1994English

MEK Inhibition Induces Differentiation in RAS-Driven Rhabdomyosarcoma

Cancer Discovery
Oncology
2018English

Notch Pathway Inhibition Significantly Reduces Rhabdomyosarcoma Invasiveness and Mobility in Vitro

Clinical Cancer Research
Cancer ResearchOncology
2010English

Clonal Dominance of CD133+ Subset Population as Risk Factor in Tumor Progression and Disease Recurrence of Human Cutaneous Melanoma

International Journal of Oncology
Cancer ResearchOncology
2012English

Novel Levamisole Derivative Induces Extrinsic Pathway of Apoptosis in Cancer Cells and Inhibits Tumor Progression in Mice

PLoS ONE
Multidisciplinary
2012English

Mitochondria-To-Nucleus Stress Signaling Induces Phenotypic Changes, Tumor Progression and Cell Invasion

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2001English

Conservative Management of Primary Vaginal Endodermal Sinus Tumor and Rhabdomyosarcoma

Oncotarget
Oncology
2017English

A Subset of Anti-Hla Antibodies Induces FcγRIIa-dependent Platelet Activation

Haematologica
Hematology
2018English

A Small Molecule Targeting the Transmembrane Domain of Death Receptor P75NTR Induces Melanoma Cell Death and Reduces Tumor Growth

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy